3,4-dihydroxyphenylacetic acid has been researched along with Diabetic Neuropathies in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, H | 1 |
| Inagaki, M | 1 |
| Ito, S | 1 |
| Gotoh, Y | 1 |
| Oguchi, K | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Diabetic Neuropathies
| Article | Year |
|---|---|
Measurement of catecholamine metabolites: assessment of autonomic impairment in diabetic patients treated by hemodialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Diabetic Neuropathies; Dopamine; | 2000 |